Key Laboratory of Systems Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, People's Republic of China.
PLoS One. 2009 Dec 2;4(12):e8126. doi: 10.1371/journal.pone.0008126.
More and more people are concerned by the risk of unexpected side effects observed in the later steps of the development of new drugs, either in late clinical development or after marketing approval. In order to reduce the risk of the side effects, it is important to look out for the possible xenobiotic responses at an early stage. We attempt such an effort through a prediction by assuming that similarities in microarray profiles indicate shared mechanisms of action and/or toxicological responses among the chemicals being compared. A large time course microarray database derived from livers of compound-treated rats with thirty-four distinct pharmacological and toxicological responses were studied. The mRMR (Minimum-Redundancy-Maximum-Relevance) method and IFS (Incremental Feature Selection) were used to select a compact feature set (141 features) for the reduction of feature dimension and improvement of prediction performance. With these 141 features, the Leave-one-out cross-validation prediction accuracy of first order response using NNA (Nearest Neighbor Algorithm) was 63.9%. Our method can be used for pharmacological and xenobiotic responses prediction of new compounds and accelerate drug development.
越来越多的人关注新药开发后期(晚期临床开发或上市后)观察到的意外副作用的风险。为了降低副作用的风险,早期发现可能的外来生物反应很重要。我们通过假设在比较的化学物质之间存在微阵列谱的相似性表明共同的作用机制和/或毒理学反应来进行这样的尝试。从具有三十四种不同药理和毒理反应的化合物处理大鼠的肝脏中获得了一个大型时间过程微阵列数据库。使用 mRMR(最小冗余最大相关性)方法和 IFS(增量特征选择)来选择一个紧凑的特征集(141 个特征),以减少特征维度和提高预测性能。使用这 141 个特征,使用 NNA(最近邻算法)进行一阶响应的留一法交叉验证预测准确性为 63.9%。我们的方法可用于新化合物的药理和外来生物反应预测,从而加速药物开发。